Skip to main content
SpringerLink
Log in

Die Frau in der Schwangerschaft in der Intensivmedizin

  • Chapter
HerzAkutMedizin

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel 6

  1. Abi-Gerges N, Small GB, Lawrence CL, Hammond TG, Valentin JP, Pollard CE (2004) Evidence for gender differences in electrophysiological properties of canine Purkinje fibres. British Journal of Pharmacology 142:1255–1264

    Article  PubMed  CAS  Google Scholar 

  2. Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, Stampfer MJ, Manson JA (2003) Prospective study of sudden cardiac death among women in the United States. Circulation 107:2096–2101

    Article  PubMed  Google Scholar 

  3. Anderer G, Hellmeyer L, Tekesin I, Schmidt S (2005) Kombinationstherapie einer fetalen supraventrikulären Tachykardie mit Flecainid und Digoxin. Z Geburtshilfe Neonatol 209:34–37

    Article  PubMed  CAS  Google Scholar 

  4. Arya A (2005) Gender-related differences in ventricular repolarization: beyond gonadal steroids. J Cardiovasc Electophysiol 16:525–527

    Article  Google Scholar 

  5. Barron WM, Mujais SK, Zinamam M, Bravo EL, Lindheimer MD (1986) Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. Am J Obstet Gynecol 154:80–84

    PubMed  CAS  Google Scholar 

  6. Bates SM, Ginsberg JS (2002) How we manage venous thromboembolism during pregnancy. Blood 100:3470–3478

    Article  PubMed  CAS  Google Scholar 

  7. Bazett HC (1920) An analysis of the time-relations of electrocardiogramms. Heart 7:353–370

    Google Scholar 

  8. Bednar MM, Harrigan EP, Ruskin JN (2002) Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc. Am J Cardiol 89:1316–1319

    Article  PubMed  CAS  Google Scholar 

  9. Ben Farhad M, Gamrha H, Betbout F, Maatouk F, Jarrar M, Addad F, Tiss M, Mammami S, Chabbani I, Thaalbi R (1997) Percutaneous ballon mitral commissurotomy during pregnancy. Heart 77:564–567

    Google Scholar 

  10. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952

    PubMed  CAS  Google Scholar 

  11. Blaustein MP, Robinson SW, Gottlieb SS, Balke CW, Hamlyn JM (2003) Sex, digitalis, and the sodium pump. Mol Interv 3:68–72

    Article  PubMed  CAS  Google Scholar 

  12. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, Brogan GX Jr, Boden WE, Roe MT, Ohman EM, Gibler WB, Newby LK, CRUSADE Investigators (2005) Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 45:832–837

    Article  PubMed  Google Scholar 

  13. Borghi C, Esposti DD, Cassani A, Immordino V, Bovicelli L, Ambrosioni E (2002) The treatment of hypertension in pregnancy. J Hypertens 20:S52–S56

    Article  CAS  Google Scholar 

  14. Bourassa MG, Gurne O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M, Johnstone DE, Yusuf S (1993) Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol 22:14A–19A

    PubMed  CAS  Google Scholar 

  15. Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation; 5th edn. Williams & Wilkins, Baltimore

    Google Scholar 

  16. Brown MA, Buddie ML (1997) What’s a name? Problems with the classification of hypertension in pregnancy. J Hypertens 15:1049–1054

    Article  PubMed  CAS  Google Scholar 

  17. Bugiardini R (2005) Normal coronary arteries: clinical implications and further classification. Herz 30(1):3–7

    Article  PubMed  Google Scholar 

  18. Burke JH, Goldberger JJ, Ehlert FA, Kruse JT, Parker MA, Kadish AH (1996) Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 100:537–543

    Article  PubMed  CAS  Google Scholar 

  19. Burke AP, Farb A, Malcom GT (1998) Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 97:2110–2116

    PubMed  CAS  Google Scholar 

  20. Buttar HS (1997) An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 176:61–71

    Article  PubMed  CAS  Google Scholar 

  21. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR (1990) Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 65:1112–1116

    Article  PubMed  CAS  Google Scholar 

  22. Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infraction Arrhythmia Trila Investigators (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349:675–682

    Article  PubMed  CAS  Google Scholar 

  23. Cardosi RJ, Chez RA (1998) Magnesium sulfate, maternal hypothermia, and fetal bradycardia with loss of heart rate variability. Obstet Gynecol 92:691–693

    Article  PubMed  CAS  Google Scholar 

  24. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB (1992) Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86(4):1099–1107

    PubMed  CAS  Google Scholar 

  25. Chan WS, Anand S, Ginsberg JS (1994) Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160:191–196

    Article  Google Scholar 

  26. Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, Rubison M (1998) Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 158:981–988

    Article  PubMed  CAS  Google Scholar 

  27. Chiang CE (2004) Congenital and acquired long QT syndrome. Cardiol Rev 12:222–234

    Article  PubMed  Google Scholar 

  28. Chow T, Galvin J, McGowern B (1998) Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 82:58I–62I

    Article  PubMed  CAS  Google Scholar 

  29. Cho L, Topol EJ, Balog C, Foody JM, Booth JE, Cabot C, Kleiman NS, Tcheng JE, Califf R, Lincoff AM (2000) Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPIS-TENT trials. J Am Coll Cardiol 36:381–386

    Article  PubMed  CAS  Google Scholar 

  30. Cleary-Goldmann J, Salva CR, Infeld JI, Robinson JN (2003) Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy. J Matern Fetal Neonatal Med 14:132–135

    Google Scholar 

  31. Cohn NJ, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M et al (1991) A comparison of enalapril with hydralazine and isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303–310

    Article  PubMed  CAS  Google Scholar 

  32. Cohn JN, Tognoni G, for the Valsartan Heart Failure Trial Investigators (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667–1675

    Article  PubMed  CAS  Google Scholar 

  33. Collins R, Yusuf S, Peto R (1985) Overview of randomised trials of diuretics in pregnancy. Br Med J (Clin Res Ed) 290:17–23

    Article  CAS  Google Scholar 

  34. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 21:2071–2078

    Article  PubMed  CAS  Google Scholar 

  35. Copel JA, Kleiman CS (1989) Fetal echocardiography in the diagnosis and management of fetal heart disease. Clin Diagn Ultrasound 25:67–83

    PubMed  CAS  Google Scholar 

  36. Curry JJ, Quintana FJ (1970) Myocardial infarction with ventricular fibrillation during pregnancy treated by direct current defibrillation with fetal survival. Chest 58:82–84

    PubMed  CAS  Google Scholar 

  37. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kris-tiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, LIFE Study Group (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For End-point reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995–1003

    Article  PubMed  Google Scholar 

  38. Dalvi BV, Chaudhuri A, Kulkarni HL, Purushottam KA (1992) Therapeutic guidelines for congenital heart block presenting in pregnancy. Obstet Gynecol 79:802–804

    PubMed  CAS  Google Scholar 

  39. Danielsson BR, Azarbayjani F, Skold AC, Webster WS (1997) Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology 56:271–281

    Article  PubMed  CAS  Google Scholar 

  40. DeSilva RA, Graboys TB, Podrid PJ, Lown B (1980) Cardioversion and defibrillation. Am Heart J 100:881–895

    Article  PubMed  CAS  Google Scholar 

  41. Deutsche Liga zur Bekämpfung des hohen Blutdruckes e.V. (1999) Hochdruck in der Schwangerschaft und während der Stillperiode. Merkblatt. Deutsche Hypertoniegesellschaft

    Google Scholar 

  42. Dickstein K, Kjekshus J (2002) Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 360:752–760

    Article  PubMed  CAS  Google Scholar 

  43. Dizon-Townson D (2002) Pregnancy-related venous thromboembolism. Clin Obstet Gynecol 45:363–369

    Article  PubMed  Google Scholar 

  44. Dominguez A, Iturralde P, Hermosillo AG, Colin L, Kershenovich S, Garrido LM (1999) Successful radiofrequency ablation of an accessory pathway during pregnancy. Pacing Clin Electrophysiol 22:131–134

    Article  PubMed  CAS  Google Scholar 

  45. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R for Grupo de Estudio de la Sobrevida en la Insufficiencia Cardiaca en Argentina (GESICA) (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 344:493–98

    Article  PubMed  CAS  Google Scholar 

  46. Drici MD, Clement N (2001) Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Safe 24:575–585

    Article  CAS  Google Scholar 

  47. Edwards FH, Carey JS, Grover FL, Bero JW, Harzt RS (1998) Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 66:125–131

    Article  PubMed  CAS  Google Scholar 

  48. Facchini M, Bauersfeld U, Fasnacht M, Candinas R (2000) Mütterliche Herzrhythmusstörungen während der Schwangerschaft. Schweiz Med Wochenschr 130:1962–1969

    PubMed  CAS  Google Scholar 

  49. Fasnacht MS, Jaeggi E (2001) Pränatale und genetische Aspekte angeborener Herzfehler. Therapeutische Umschau 58:70–75

    Article  PubMed  CAS  Google Scholar 

  50. Fasnacht MS, Günthard J (2004) Fetale Kardiologie beinhaltet nicht nur fetale Echokardiografie. Pediatrica 15:27–29

    Google Scholar 

  51. Fernandes LS, Tcheng JE, O’Shea JC, Weiner B, Lorenz TJ, Pacchiana C, Berdan LG, Maresh KJ, Joseph D, Madan M, Mann T, Kilaru R, Hochman JS, Kleiman NS, ESPRIT Investigators (2002) Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT Study. J Am Coll Cardiol 40:1085–1091

    Article  PubMed  Google Scholar 

  52. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343:311–322

    Google Scholar 

  53. Finlay AY, Edmunds V (1979) DC cardioversion in pregnancy. Br J Clin Pract 33:88–94

    PubMed  CAS  Google Scholar 

  54. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E, for the ACE Inhibitor Myocardial Infarction Collaborative Group (2000) Long-term ACE inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 355:1575–1581

    Article  PubMed  CAS  Google Scholar 

  55. Fouron JC, Fournier A, Proulx F, Lamarche J, Bigras JL, Boutin C, Brassard M, Gamache S (2003) Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 89:1211–1216

    Article  PubMed  Google Scholar 

  56. Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273:1450–1456

    Article  PubMed  CAS  Google Scholar 

  57. Gembruch U, Hansmann M, Bald R (1988) Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs. Fetal Ther 3:210–215

    Article  PubMed  CAS  Google Scholar 

  58. Gembruch U, Hansmann M, Redel DA, Bald R (1988) Intrauterine therapy of fetal tachyarrhythmias: intraperitoneal administration of antiarrhythmic drugs to the fetus in fetal tachyarrhythmias with severe hydrops fetalis. J Perinat Med 16:39–44

    Article  PubMed  CAS  Google Scholar 

  59. Gembruch U, Manz M, Bald R, Ruddel H, Redel DA, Schlebusch H, Nitsch J, Hansmann M (1989) Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis. Am Heart J 118:1335–1338

    Article  PubMed  CAS  Google Scholar 

  60. Ghali JK, Pina IL, Gottlieb SS, Deedwania PC, Wikstrand JC (2002) Metoprolol CR/XL in female patients with heart failure: analysis of the experience in metoprolol extended-release randomized intervention trial in heart failure (MERIT-HF). Circulation 105:1585–1591

    Article  PubMed  CAS  Google Scholar 

  61. Ginsberg JS, Greer I, Hirsh J (2001) Use of anti-thrombotic agents during pregnancy. Chest 119: 122S–131S

    Article  PubMed  CAS  Google Scholar 

  62. Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP, Braunwald E (2002) Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 288:3124–3129

    Article  PubMed  Google Scholar 

  63. Gleiter CH, Mörike KE (2002) Clinical pharmacokinetics of candesartan. Clin Pharmacokinet 41:7–17

    Article  PubMed  CAS  Google Scholar 

  64. Gras D, Mabo P, Kermarrec A, Bazin P, Varin C, Daubert C (1992) Radiofrequency ablation of atrioventricular conduction during the 5th month of pregnancy. Arch Mal Coeur Vaiss 85:1873–1877

    PubMed  CAS  Google Scholar 

  65. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML, MADIT-II Investigators (2004) Analysis of mortality events in the Multi-center Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 43:1459–1465

    Article  PubMed  Google Scholar 

  66. Greer IA (2001) Management of venous thromboembolism in pregnancy. Best Pract Res Clin Obstet Gynaecol 15:583–603

    Article  PubMed  CAS  Google Scholar 

  67. Grosso S, Bernardi R, Cioni M, Morgese G (1998) Transient neonatal hypothyoidism after gestational exposure to amiodarone: a follow-up of two cases. J Endocrinol Invest 21:699–702

    PubMed  CAS  Google Scholar 

  68. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397–402

    Google Scholar 

  69. Gurwitz JH, Gore JM, Goldberg RJ, Barron HV, Breen T, Rundle AC, Sloan MA, French W, Rogers WJ (1998) Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the national registry of myocardial infarction 2. Ann Intern Med 129:597–604

    PubMed  CAS  Google Scholar 

  70. Habib A, McCarthy JS (1977) Effects on the neonate of propranolol admininstered during pregnancy. J Pediatr 91:808–811

    Article  PubMed  CAS  Google Scholar 

  71. Halle H (2004) Peripartales Management bei herzkranken Schwangeren aus geburtshilflicher Sicht. In: Stangl V, Baumann G (Hrsg) Kardiovaskuläre Notfälle bei Frauen. Steinkopff, Darmstadt, S 33–36

    Google Scholar 

  72. Heinroth K, Knitza R, Werdan K (2003) Schwangerschaft. In: Werdan K, Trappe HJ, Zerkowski HR (Hrsg) Das Herzbuch. Urban & Fischer, München Jena, S 882–891

    Google Scholar 

  73. Hoffmann E, Reithmann C, Neuser H, Nimmermann P, Remp T, Steinbeck G (1998) Repetitive monomorphe ventrikuläre Tachycardie (Typ Gallavardin): Klinische und elektrophysiologische Charakteristika von 20 Patienten. Z Kardiol 87:353–363

    Article  PubMed  CAS  Google Scholar 

  74. Hohnloser SH, Meinertz T, Zehender M, Geibel A, Just H (1988) Auslösung und Verstärkung von Herzrhythmusstörungen durch Antiarrhythmika. Internist 29:338–344

    PubMed  CAS  Google Scholar 

  75. Huang H, Lin Q, Zhang L (1997) Clinical observation of cardiac pacemaker in pregnant women. Chuang Hua Fu Chan Ko Tsa Chih 32:345–346

    CAS  Google Scholar 

  76. Hubinont C, Debauche C, Bernard P, Sluysmans T (1998) Resolution of fetal tachycardia and hydrops by a single adenosine administration. Obstet Gyne-col 92:718–720

    Article  CAS  Google Scholar 

  77. Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M, Sheldon R, Talajic M, Dorian P, Newman D (2001) New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 103:2365–2370

    PubMed  CAS  Google Scholar 

  78. Isaacs JD, Mulholland DH, Hess LW, Albert JR, Martin RW (1993) Pregnancy in a woman with an automatic implantable cardioverter defibrillator: a case report. J Reprod Med 36:487–488

    Google Scholar 

  79. Ishii K, Chiba Y, Sasaki Y, Kawamata K, Miyashita S (2003) Fetal atrial tachycardia diagnosed by magnetocardiografy and direct fetal electrocardiografy. A case report of treatment with propranolol hydrochloride. Fetal Diagn Ther 18:463–466

    Article  PubMed  Google Scholar 

  80. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2:349–360

    Google Scholar 

  81. Israili ZH (2000) Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens 14:73–86

    Article  Google Scholar 

  82. James AF, Choisy SCM, Hancox JC (2005) Recent advances in understanding sex differences in cardiac repolarization. Progress in biophysics and molecular biology, article in press. www.sciencedir-ect.com

    Google Scholar 

  83. Joglar JA, Page RL (1999) Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 20:85–94

    Article  PubMed  CAS  Google Scholar 

  84. Julian DG, Wenger NK (1997) Arrhythmias and the use of implantable cardioverter-defibrillators. Women & Heart Disease 22:365–373

    Google Scholar 

  85. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, for the European Myocardial Infarct Amiodarone Trial Investigators (1997) Randomised trial of effect of amiodarone on mortality in patients with left-ventricualr dysfunction after recent myocardial infarction: EMIAT. Lancet 349:667–674

    Article  PubMed  CAS  Google Scholar 

  86. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE Trial Group (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363:2022–2031

    Article  PubMed  CAS  Google Scholar 

  87. Kearney P, Singh H, Hutter J, Khan S, Lee G, Lucey J (1993) Spontaneous coronary artery dissection: a report of three cases and review of the literature. Postgrad Med J 69:940–945

    Article  PubMed  CAS  Google Scholar 

  88. Kemkes-Matthes B (2001) Veränderungen des Gerinnungssystems in der Schwangerschaft. Z Kardiol 90:45–48

    Article  PubMed  Google Scholar 

  89. Khositseth A, Ramin KD, O’Leary PW, Porter CJ (2003) Role of amiodarone in the treatment of fetal supraventricular tachyarrhythmias and hydrops fetalis. Pediatr Cardiol 24:454–456

    Article  PubMed  CAS  Google Scholar 

  90. Klein HH, Pich S (2003) Physiologische Änderungen des Herz-Kreislauf-Systems in der Schwangerschaft. Herz 28:173–174

    Article  PubMed  Google Scholar 

  91. Ko WJ, Ho HN, Chu SH (1998) Postpartum myocardial infarction rescued with an intraaortic balloon pump and extracorporeal membrane oxygenator. Int J Cardiol 5;63:81–84

    Article  Google Scholar 

  92. Köhler F, Fotuhi P, Baumann G (2001) Schwangerschaft und angeborene Herzfehler. Z Kardiol 90:30–35

    PubMed  Google Scholar 

  93. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150

    Article  PubMed  CAS  Google Scholar 

  94. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917

    Article  PubMed  CAS  Google Scholar 

  95. Kyrle PA, Eichinger S (2005) Deep vein thrombosis. Lancet 365:1163–1174

    Article  PubMed  Google Scholar 

  96. Lagrange F, Vergnes C, Brun JL, Paolucci F, Nadal T, Leng JJ, Saux MC, Banwarth B (2002) Absence of placental transfer of pentasaccharide (Fondapar-inux, Arixtra) in the dually perfused human cotyledon in vitro. Thromb Haemost 87(5):831–835

    PubMed  CAS  Google Scholar 

  97. Lau CP, Lee CP, Wong CK, Cheng CH, Leung WH (1990) Rate responsive pacing with a minute ventilation sensing pacemaker during pregnancy and delivery. Pacing Clin Electrophysiol 13:158–163

    Article  PubMed  CAS  Google Scholar 

  98. Legato M (2000) Gender and the heart: sex-specific differences in normal anatomy and physiology. J Gend Specif Med 3:15–18

    PubMed  CAS  Google Scholar 

  99. Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ (1996) Sex differences in risk of torsades de pointes with d,l-sotalol. Circulation 94:2535–2541

    PubMed  CAS  Google Scholar 

  100. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996) The progression from hypertension to congestive heart failure. JAMA 275(20):1557–1562

    Article  PubMed  CAS  Google Scholar 

  101. Liao D, Cai J, Rosamond WD, Barnes RW, Hutch-inson RG, Whitsel EA, Rautaharju P, Heiss G (1997) Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Community Study. Am J Epidemiol 145:696–706

    PubMed  CAS  Google Scholar 

  102. Liu K, Ballew C, Jacobs DR Jr, Sidney S, Savage PJ, Dyer A, Hughes G, Blanton MM (1989) Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CAR-DIA Study. Hypertension 14:218–226

    CAS  Google Scholar 

  103. Liu S, Yuan S, Hertervig E, Kongstad O, Olsson SB (2001) Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol 34:295–301

    Article  PubMed  CAS  Google Scholar 

  104. Mackay FJ, Pearce GL, Mann RD (1999) Cough and angiotensin II receptor antagonists: cause or confounding? Br J Clin Pharmacol 47:111–114

    Article  PubMed  CAS  Google Scholar 

  105. Magee LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G (1995) Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 172:1307–1311

    Article  PubMed  CAS  Google Scholar 

  106. Magee LA, Nulman I, Rovet JF, Koren G (2000) Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 88:15–26

    Article  PubMed  CAS  Google Scholar 

  107. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270:2590–2597

    Article  PubMed  CAS  Google Scholar 

  108. Mallik S, Vaccarino V (2004) Outcomes of thrombolytic therapy for acute myocardial infarction in women. Prog Cardiovasc Dis 47:58–71

    Article  PubMed  Google Scholar 

  109. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A (2005) Contribution of atrial fibrillation to incidence and outcome of ischemic stroke. Stroke 36:1115–1119

    Article  PubMed  Google Scholar 

  110. Matsuo K, Akahoshi M, Seto S, Yano K (2003) Disappearance of the Brugada-type electrocardiogram after surgical castration: a role for testosterone and an explanation for the male preponderance. Pacing Clin Electrophysiol 26:1551–1553

    Article  PubMed  Google Scholar 

  111. Maulik D (1989) Basic principles of Doppler ultrasound as applied in obstetrics. Clin Obstet Gynecol 32:628–644

    PubMed  CAS  ADS  Google Scholar 

  112. McCurdy CM Jr, Rutherford SE, Coddington CC (1993) Syncope and sudden arrhythmic death complicating pregnancy, A casde report of Romano-Ward syndrome. J Reprod Med 38:233–234

    PubMed  Google Scholar 

  113. McSweeney JC, Cody M, O’Sullivan P, Elberson K, Moser DK, Garvin BJ (2003) Women’s early warning symptoms of acute myocardial infarction. Circulation 108:2619–2623

    Article  PubMed  Google Scholar 

  114. Mehta NJ, Mehta RN, Khan IA (2001) Peripartum cardiomyopathy: clinical and therapeutic aspects. Angiology 52:759–762

    Article  PubMed  CAS  Google Scholar 

  115. Mendelson CL (1956) Disorders of the heartbeat during pregnancy. Am J Obstet Gynecol 72:1268–1270

    PubMed  CAS  Google Scholar 

  116. Merri M, Benhorin J, Alberti M, Locati E, Moss AJ (1989) Electrocardiografic quantitation of ventricular repolarization. Circulation 80:1301–1308

    PubMed  CAS  Google Scholar 

  117. Meyerburg RJ, Cox MM, Interian A Jr, Mitrani R, Girgis I, Dylewski J, Castellanos A (1999) Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiologic procedures. Am J Cardiol 83:1049–1054

    Article  Google Scholar 

  118. Middeldorp S, Libourel EJ, Hamulyak K, Van der Meer J, Buller HR (2001) The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol 113:553–555

    Article  PubMed  CAS  Google Scholar 

  119. Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyak K, van Der Meer J, Prins MH, Buller HR (2001) A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 135:322–327

    PubMed  CAS  Google Scholar 

  120. Moll W (2001) Die physiologische Kreislaufumstellung in der Schwangerschaft — Ihre Bedeutung für kardiale Erkrankungen. Z Kardiol 90:2–9

    Article  PubMed  Google Scholar 

  121. Mozo de Rosales F, Moreno J, Bodegas A, Melchor JC, Fernandez Lebrez L, Aranguren G (1994) Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome. Eur J Obstet Gynecol 56:63–66

    Article  CAS  Google Scholar 

  122. Mueller C, Neumann FJ, Roskamm H, Buser P, Hodgson JM, Perruchoud AP, Buettner HJ (2002) Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention: a prospective study in 1450 consecutive patients. J Am Coll Cardiol 40:245–250

    Article  PubMed  Google Scholar 

  123. Myers JE, Baker PN (2002) Hypertensive diseases and eclampsia. Curr Opin Obstet Gynecol 14:119–125

    Article  PubMed  Google Scholar 

  124. Nagel BHP, Neudorf U, Hanssler L, Kuhn U, Schmaltz AA (2000) Therapeutische Optionen bei fetaler Tachyarrhythmie (Problems of therapy of fetal life-threatening dysrhythmias). Monatsschr Kinderheilkd 148:666–672

    Article  Google Scholar 

  125. Nakagawa M, Takahashi N, Nobe S, Ichinose M, Ooie T, Yufu F, Shigematsu S, Hara M, Yonemo-chi H, Saikawa T (2002) Gender differences in various types of idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol 13:633–638

    Article  PubMed  Google Scholar 

  126. Natale A, Davidson T, Geiger MJ, Newby K (1997) Implantable cardioverter-defibrillators and pregnancy. A safe combination? Circulation 96: 2808–2812

    PubMed  CAS  Google Scholar 

  127. Oakley C (1997) Heart disease in pregnancy. BMJ 5–16, S 237–245

    Google Scholar 

  128. Ogburn PL Jr, Schmidt G, Linman J, Cefalo RC (1982) Paroxysmal tachycardia and cardioversion during pregnancy. J Reprod Med 27:359–362

    PubMed  Google Scholar 

  129. Pagdad SV, Barmade AB, Toal SC, Vora AM, Lokhandwala YY (2004) “Rescue” radiofrequency ablation for atrial tachycardia presenting as cardiomyopathy in pregnancy. Indian Heart J 56: 245–247

    Google Scholar 

  130. Page RL, Shenasa H, Evans J, Sorrentino RA, Wharton JM, Prystowsky EN (1993) Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with a right bundle branch block, left axis pattern. Pace Clin Electrophysiol 16:327–336

    Article  CAS  Google Scholar 

  131. Page RL (1995) Treatment of arrhythmias during pregnancy. Am Heart J 130:871–876

    Article  PubMed  CAS  Google Scholar 

  132. Peters RW, Gold MR (2004) The influence of gender on arrhythmias. Cardiol Rev 12:97–105

    Article  PubMed  Google Scholar 

  133. Peterson ED, Lansky AJ, Kramer J, Anstrom K, Lanzilotta MJ (2001) Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 88:359–364

    Article  PubMed  CAS  Google Scholar 

  134. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM (2003) Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893–1906

    Article  PubMed  CAS  Google Scholar 

  135. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, Michelson EL, Olofsson B, Östergren J, Yusuf S and CHARM Investigators and Committees (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet 362:759–766

    Article  PubMed  CAS  Google Scholar 

  136. Pillans PI, Coulter DM, Black P (1996) Angiooedema and urticaria with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol 51:123–126

    Article  PubMed  CAS  Google Scholar 

  137. Pina IL, Buchter C (2003) Heart failure in women. Cardiol Rev 6:337–344

    Google Scholar 

  138. Piper JM, Berkus M, Ridgway LE (1992) Pregnancy complicated by chronic cardiomyopathy and an automatic implantable cardioverter defibrillator. Am J Obstet Gynecol 167:506–507

    PubMed  CAS  Google Scholar 

  139. Pires LA, Sethuraman B, Guduguntla VD, Todd KM, Yamasaki H, Ravi S (2002) Outcome of women versus men with ventricular tachyarrhythmias treated with the imlantable cardioverter defibrillator. J Cardiovasc Electrophysiol 13: 563–568

    Article  PubMed  Google Scholar 

  140. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone in morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717

    Article  PubMed  CAS  Google Scholar 

  141. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial — the Losartan Heart Failure Survival Study ELITE II. Lancet 355:1582–1587

    Article  PubMed  CAS  Google Scholar 

  142. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldoster-one blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321

    Article  PubMed  CAS  Google Scholar 

  143. Plomp TA, Vulsma T, de Vijlder JJ (1992) Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol 43:201–207

    Article  PubMed  CAS  Google Scholar 

  144. Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, Pitt B, Schwartz PJ, Veltri EP, Waldo AL, for the SWORD Investigators (1998) Mortality in the Survival With ORal D-Sotalol (SWORD) trial: why did patients die? Am J Cardiol 81:869–876

    Article  PubMed  CAS  Google Scholar 

  145. Rademaker M (2001) Do women have more adverse drug reactions? Am J Clin Dermatol 2:349–351

    Article  PubMed  CAS  Google Scholar 

  146. Rahilly GT, Prystowsky EN, Zipes DP, Nacarelli GV, Jackman WM, Heger JJ (1982) Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. Am J Cardiol 50:459–468

    Article  PubMed  CAS  Google Scholar 

  147. Ramsewak S, Persad P, Perkins S, Narayansingh G (1992) Twin pregnancy in a patient with complete heart block. A case report. Clin Exp Obstet Gynecol 19:166–167

    PubMed  CAS  Google Scholar 

  148. Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347: 1403–1411

    Article  PubMed  CAS  Google Scholar 

  149. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289:871–878

    Article  PubMed  CAS  Google Scholar 

  150. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A (1992) Sex differences in the evolution of the electrocardiografic QT interval with age. Can J Cardiol 8:690–695

    PubMed  CAS  Google Scholar 

  151. Rogge C, Geibel A, Bode C, Zehender M (2004) Herzrhythmusstörungen und plötzlicher Herztod bei Frauen. Z Kardiol 93:427–438

    Article  PubMed  CAS  Google Scholar 

  152. Rossi ML, Merlini PA, Ardissino D (2001) Percutaneous coronary revascularisation in women. Thromb Res 103:S 105–111

    Article  Google Scholar 

  153. Rotmensch HH, Elkayam U, Frishman W (1983) Antiarrhythmic drug therapy during pregnancy. Ann Intern Med 98:487–497

    PubMed  CAS  Google Scholar 

  154. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE, and the MUSTT Investigators (2004) Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 15:993–998

    Article  PubMed  Google Scholar 

  155. Samuel C Siu, Jack M Colman (2001) Heart disease and pregnancy. Heart 85:710–715

    Article  PubMed  CAS  Google Scholar 

  156. Schaefer C, Spielmann H (2001) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban & Fischer, München Jena, S 2–26

    Google Scholar 

  157. Schellong SM, Schwarz T (2002) Differential therapy of deep venous thrombosis of the leg veins. Internist (Berl) 42:39–46

    Google Scholar 

  158. Schuster HP, Trappe HJ (2005) EKG-Kurs für Isabel, 4. Aufl. Thieme, Stuttgart, S 1–314

    Google Scholar 

  159. Sermer M, Colman J, Siu S (2003) Pregnancy complicated by heart disease: a review of Canadian experience. J Obstet Gynaecol 23:540–544

    Article  PubMed  CAS  Google Scholar 

  160. Shekelle PG, Rich MW, Morton SC, Atkinson W, Tu W, Maglione M, Rhodes S, Barrett M, Fonarow GC, Greenberg B, Heidenreich PA, Knabel T, Konstam MA, Steimle A, Warner Stevenson L (2003) Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status. J Am Coll Cardiol 41:1529–1538

    Article  PubMed  CAS  Google Scholar 

  161. Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 79:1061–1064

    Article  PubMed  CAS  Google Scholar 

  162. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D (1995) the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. NEJM 333:77–82

    Article  PubMed  CAS  Google Scholar 

  163. Skaluba SJ, Berkson DM (2001) Peripartum cardiomyopathy: case report and literature review. Congest Heart Fail 7:88–92

    PubMed  Google Scholar 

  164. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P (2000) Peripartum cardiomyopathy: analysis od clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 35:701–705

    Article  PubMed  CAS  Google Scholar 

  165. Somerville J (1992) The problem — an overview. In: Hess J, Sutherland GR (eds) Congenital heart disease in adolescents and adults. Kluwer Academic Publishers, Dordrecht, pp 1–13

    Google Scholar 

  166. Stangl V, Baumann G, Stangl K (2001) Schwangerschaftsrisiken bei erworbenen Herzerkrankungen. Z Kardiol 90Suppl 4:16–29

    PubMed  Google Scholar 

  167. Stone GW, Grines CL, Browne KF, Marco J, Roth-baum D, O’Keefe J, Hartzler GO, Overlie P, Donohue B, Chelliah N et al (1995) Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 75:987–992

    Article  PubMed  CAS  Google Scholar 

  168. Strocchi E, Malini PL, Valtancoli G, Ricci C, Bassein L, Ambrosioni E (1992) Cough during treatment with angiotensin-converting enzyme inhibitors. Analysis of predisposing factors. Drug Invest 4:69–72

    Google Scholar 

  169. Strömberg A, Martensson J (2003) Gender differences in patients with heart failure. Eur J Cardiovasc Nursing 2:7–18

    Article  Google Scholar 

  170. Suttorp MJ, Kingma H, Koomen EM, Hof AV, Tijssen JG, Lie KI (1993) Recurrence of atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 71:710–713

    Article  PubMed  CAS  Google Scholar 

  171. Talbott E, Kuller LH, Detre K, Perper J (1977) Biologic and psychosocial risk factors of sudden death from coronary disease in white women. Am J Cardiol 117:859–864

    Google Scholar 

  172. Tan HL, Lie KI (2001) Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 22:458–464

    Article  PubMed  CAS  Google Scholar 

  173. Tandon S, Hankins SR, Le Jemtel TH (2002) Clinical profile in chronic heart failure in elderly women. Am J Geriatr Cardiol ll(5):318–323

    Google Scholar 

  174. Task Force on Pulmonary Embolism, European Society of Cardiology (2000) Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 21:1301–1336

    Article  Google Scholar 

  175. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24:761–781

    Article  Google Scholar 

  176. Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A (1993) Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 72:838–840

    Article  PubMed  CAS  Google Scholar 

  177. The Cardiac Arrhythmia Suppression Trial Investigators (CAST) (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. NEJM 321:406–412

    Google Scholar 

  178. Torp-Pederson C, Moller M, Bloch-Thomsen PE, Kober L, Sandoe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm JA (1999) Dofetilide in patients with congestive heart failure and left ventricular dysfunction. NEJM 341:857–865

    Article  Google Scholar 

  179. Trappe HJ (1996) Therapie von Herzrhythmusstörungen ohne Antiarrhythmika. Möglichkeiten und Indikationen. In: Gerok W, Hartmann F, Pfreundschuh M, Philipp T, Schuster HP, Sy-brecht GW (Hrsg) Klinik der Gegenwart. Urban & Schwarzenberg, München 14:Sl–25

    Google Scholar 

  180. Trappe HJ (1997) Akuttherapie supraventriku-lärer Tachykardien: Adenosin oder Ajmalin? In-tensivmed 34:452–461

    Article  Google Scholar 

  181. Trappe HJ, Schuster HP (2000) Brugada-Syndrom. Definition, Diagnostik, Therapie, Prog-nose. Intensivmed 37:680–687

    Article  Google Scholar 

  182. Trappe HJ (2001) Amiodaron. Intensivmed 38: 169–178

    Article  Google Scholar 

  183. Turrentine MA, Braems G, Ramirez MM (1995) Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gy-necol Surv 50:534–541

    Article  CAS  Google Scholar 

  184. Vaccarino V, Abramson JL, Veledar E, Weintraub WS (2002) Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation 105:1176–1181

    Article  PubMed  Google Scholar 

  185. Vachharajani NN, Shyu WC, Smith RA, Greene DS (1998) The effects of age and gender on the pharmacokinetics of irbesartan. Br J Clin Pharmacol 46:611–613

    Article  PubMed  CAS  Google Scholar 

  186. Varon ME, Sherer DM, Abramowicz JS, Akiyama T (1992) Maternal ventricular tachycardia associated with hypomagnesemia. Am J Obstet Gynecol 167:1352–1355

    PubMed  CAS  Google Scholar 

  187. Vaughan Williams EM (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129–147

    PubMed  CAS  Google Scholar 

  188. Verhaert D, Van Acker R (2004) Acute myocardial infarction during pregnancy. Acta Cardiol 59:331–339

    Article  PubMed  Google Scholar 

  189. Vietzke G, Baumann G, Stangl V (2004) Therapie der kardialen Dekompensation in der Schwangerschaft, in der Intensiv-und Notfallmedizin. In: Stangl V, Baumann G (Hrsg) Kardiovaskuläre Notfälle bei Frauen. Steinkopff, Darmstadt, S 3–11

    Google Scholar 

  190. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M(1999) Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33:1637–1641

    Article  PubMed  CAS  Google Scholar 

  191. Wada H, Chiba Y, Murakami M, Kawaguchi H, Kobayashi H, Kanzaki T (1996) Analysis of maternal and fetal risk in 594 pregnancies with heart disease. Nippon Sanka Fujinka Gakkai Zasshi 48:255–262

    PubMed  CAS  Google Scholar 

  192. Walsh KA, Erzi MD, Denes P (1988) Emergency treatment of tachyarrhythmias. Med Clin North Am 70:791–811

    Google Scholar 

  193. Watanabe CT, Maynard C, Ritchie JL (2001) Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol 88:848–852

    Article  PubMed  CAS  Google Scholar 

  194. Wellens HJJ, Conover MB (1992) The ECG in emergency decision making. WB Saunders Company, Philadelphia New York

    Google Scholar 

  195. Wenger N (2002) Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc Res 53:558–567

    Article  PubMed  CAS  Google Scholar 

  196. Widerhorn J, Widerhorn ALM, Rahimtoola SH, Elkayam U (1992) WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J 123:796–798

    Article  PubMed  CAS  Google Scholar 

  197. Wilson JD (1977) Embryotoxicity of drugs to man. In: Wilson JD, Frazer FC (eds) Handbook of teratology. Plenum Press, New York, pp 309–355

    Google Scholar 

  198. Wilson AM, Boyle AJ, Fox P (2004) Management of ischemic heart disease in women of child-bearing age. Int Med J 34:694–697

    Article  CAS  Google Scholar 

  199. Yap LB, Alp NJ, Forfar JC (2002) Thrombolysis for acute massive pulmonary embolism during pregnancy. Int J Cardiol 82:193–194

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizionische Klinik und Poliklinik, Campus Charité Mitte, Charité Universitätsmedizin Berlin, Schumannstr. 20/21, 10117, Berlin

    Prof. Dr. med. V. Stangl

  2. Medizinische Klinik II Marienhospital Herne, Klinikum der Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne

    Prof. Dr. med. H. -J. Trappe

Authors
  1. Prof. Dr. med. V. Stangl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. H. -J. Trappe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Herz- und Thoraxchirurgie, Universitätsspital Basel, Spitalstr. 21, 4031, Basel, Schweiz

    H. -R. Zerkowski

  2. Medizinische Klinik mit Schwerpunkt Kardiologie, Angiologie und Pneumologie, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Schumannstr. 20/21, 10117, Berlin

    G. Baumann

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Stangl, V., Trappe, H.J. (2006). Die Frau in der Schwangerschaft in der Intensivmedizin. In: Zerkowski, H.R., Baumann, G. (eds) HerzAkutMedizin. Steinkopff. https://doi.org/10.1007/3-7985-1630-8_49

Download citation

  • DOI: https://doi.org/10.1007/3-7985-1630-8_49

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1505-5

  • Online ISBN: 978-3-7985-1630-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation